Paul Peter Tak, Director, Chief Executive Officer, on September 10, 2026, sold 280,245 shares in Candel Therapeutics (CADL) for $3,160,783. Following the Form 4 filing with the SEC, Tak has control over a total of 113,321 common shares of the company, with 113,321 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1841387/000187390526000002/xslF345X05/ownership.xml
Sean P Downes, Director, Executive Chairman, on September 11, 2026, sold 20,000 shares in Universal Insurance Holdings (UVE) for $879,562. Following the Form 4 filing with the SEC, Downes has control over a total of 1,134,645 common shares of the company, with 1,084,645 shares held directly and 50,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/891166/000128704026000012/xslF345X05/wk-form4_1789163605.xml
Aaron Levie, Director, Chief Executive Officer, on September 10, 2026, sold 15,000 shares in Box (BOX) for $513,660. Following the Form 4 filing with the SEC, Levie has control over a total of 2,859,673 Class A common shares of the company, with 2,859,673 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1372612/000119312526389451/xslF345X05/ownership.xml
Geoffrey Phillips, Senior Vice President, Operations, on September 11, 2026, sold 2,500 shares in Gatx (GATX) for $443,992. Following the Form 4 filing with the SEC, Phillips has control over a total of 6,473 common shares of the company, with 1 share held directly and 6,472 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/40211/000198942126000012/xslF345X05/primarydocument.xml